Impact of thromboplastin reagents on monitoring INR in a patient with triple-positive antiphospholipid syndrome: a case report

IntroductionAntiphospholipid syndrome (APS) is an autoimmune disease characterized by a hypercoagulable state and recurrent thromboembolism (TE). Patients with triple-positive antiphospholipid antibodies (APAs) are at the highest risk of TE. As standard treatment for these patients, oral anticoagula...

Full description

Saved in:

Bibliographic Details
Main Authors:	Lóránt Varju, Zsuzsa Bagoly, Éva Ajzner, Rita Orbán-Kálmándi, Anna Zsófia Kádár, Judit Nevelős, Péter Ilonczai
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-07-01
Series:	Frontiers in Immunology
Subjects:	triple-positive antiphospholipid syndrome recurrent thromboembolism case report INR monitoring antiphospholipid antibodies
Online Access:	https://www.frontiersin.org/articles/10.3389/fimmu.2025.1591029/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!

Impact of thromboplastin reagents on monitoring INR in a patient with triple-positive antiphospholipid syndrome: a case report

Similar Items